In Q3'25, CVS's Pharmacy segment generated $59.4B in revenue, marking a strong quarterly performance driven by increased prescriptions and services. The Front Store contributed $5.2B, reflecting stable retail sales, while Premiums led with $33.7B from insurance operations, underscoring its dominant role. Other segments, including Net investment income at $0.6B and Other at $3.8B, provided supplementary growth, resulting in total revenue exceeding $102B for the quarter. From Q4'22 to Q3'25, CVS's revenue breakdown shows Premiums as the largest and fastest-growing segment, expanding from $21.4B to $33.7B with consistent upward momentum, particularly accelerating post-Q1'24 due to expanded health insurance coverage. Pharmacy revenue fluctuated between $48.4B and $59.7B, exhibiting overall stability with peaks in Q4 periods, while Front Store remained the smallest at around $5B-$6B, showing minor declines amid retail pressures. Net investment income and Other segments grew modestly from $0.3B/$2B to $0.6B/$3.8B, highlighting diversification, though Pharmacy and Premiums together accounted for over 90% of total revenue throughout the period.